Influenza A (H5N1) pandemic prototype vaccine Fluval. - Wikidata - awgldk - TriplyDB

Influenza A (H5N1) pandemic prototype vaccine Fluval.

Influenza A (H5N1) pandemic prototype vaccine Fluval.

http://www.wikidata.org/entity/Q30376553

about

A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial

P2860

Q24623902-A86380A6-6A93-4BBD-94BB-CD1FD7D73F9F

P2860

Influenza A (H5N1) pandemic prototype vaccine Fluval.

http://www.wikidata.org/entity/Q30376553

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Influenza A (H5N1) pandemic prototype vaccine Fluval.

@ast

Influenza A (H5N1) pandemic prototype vaccine Fluval.

@en

type

label

Influenza A (H5N1) pandemic prototype vaccine Fluval.

@ast

Influenza A (H5N1) pandemic prototype vaccine Fluval.

@en

prefLabel

Influenza A (H5N1) pandemic prototype vaccine Fluval.

@ast

Influenza A (H5N1) pandemic prototype vaccine Fluval.

@en

P1433

Q30376553-CC197E1A-FFC3-41D7-B55C-FF4126B062AA

P1476

Q30376553-A115F26D-7FA4-4995-84C4-825FA96803BC

P2093

Q30376553-62F77DFE-D2A9-466B-BE89-3F7CF3016DA7

P2860

Q30376553-04E6D3A2-A84F-48E0-B5B7-7F7CB73CEEF7

Q30376553-0A5E9945-034B-4CA2-B523-31E0AC8E203B

Q30376553-20FAE3BC-A967-4762-B89A-4047E80CA32A

Q30376553-235C42C9-C259-4C6D-AFCE-2A442C128187

Q30376553-26A567FA-0FE5-4CC8-9914-C0BFAB1A222B

Q30376553-28733EBB-4914-45BB-A4F5-A8F130D5F112

Q30376553-40156CAC-5663-47A2-B267-94CE0A756A0E

Q30376553-43395E38-27D8-44BF-98FC-ED2F3DFB56D0

Q30376553-4BCAAA52-95DD-49A8-82E5-E49A7E978338

Q30376553-5179384C-88E7-47E3-8803-9FFEA4680C7F

P304

Q30376553-31E60400-E762-4982-99BE-3E36BCF6E079

P31

Q30376553-D39B004F-D16D-4A72-8FE2-C56F90127110

P356

Q30376553-54287A90-D48A-45F5-8DBE-553D46959D90

P433

Q30376553-497B809E-3330-41E3-9AFD-BE0829D36972

P478

Q30376553-A1287DCE-42B2-4ED9-9971-0EDEB8217EE6

P50

Q30376553-F8B306F0-EFFD-429B-9C01-7DD9EA3C220A

P577

Q30376553-CED36A4F-44AC-454F-9C00-FFF168C0B041

P698

Q30376553-9D751BAA-E2DD-4ACC-9FD2-5F0B2E4EE5D8

P921

Q30376553-E2B0D1F5-F7F4-434D-998B-C6D74563F338

P356

P1433

Expert Review of Vaccines

P1476

Influenza A (H5N1) pandemic prototype vaccine Fluval

@en

P2093

Zoltan Vajo

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivated whole virus influenza A (H5N1) vaccine

Probable person-to-person transmission of avian influenza A (H5N1)

Vaccines against avian influenza--a race against time

Strategies for mitigating an influenza pandemic

Oseltamivir resistance during treatment of influenza A (H5N1) infection

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

P304

619-624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.09.25

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19397418

http://www.w3.org/2001/XMLSchema#string

P921